Inclusion body myositis: new insights into pathogenesis (original) (raw)

Provision of an explanation for the inefficacy of immunotherapy in sporadic inclusion body myositis: Quantitative assessment of inflammation and β-amyloid in the muscle

Joachim Voss

Arthritis & Rheumatism, 2012

View PDFchevron_right

Diagnostic value of markers of muscle degeneration in sporadic inclusion body myositis

Anthony Behin

Acta myologica : myopathies and cardiomyopathies : official journal of the Mediterranean Society of Myology / edited by the Gaetano Conte Academy for the study of striated muscle diseases, 2011

View PDFchevron_right

Inclusion body myositis: current pathogenetic concepts and diagnostic and therapeutic approaches

Frank Mastaglia

The Lancet Neurology, 2007

View PDFchevron_right

Sporadic inclusion body myositis: a continuing puzzle

Frank Mastaglia

Neuromuscular Disorders, 2008

View PDFchevron_right

Ongoing Developments in Sporadic Inclusion Body Myositis

Qiang Gang

Current Rheumatology Reports, 2014

View PDFchevron_right

Amyloid deposits and inflammatory infiltrates in sporadic inclusion body myositis: the inflammatory egg comes before the degenerative chicken

Marco Sandri

Acta neuropathologica, 2015

View PDFchevron_right

Sporadic Inclusion-Body Myositis and Hereditary Inclusion-Body Myopathies

Valerie Askanas

Archives of Neurology, 1998

View PDFchevron_right

Sporadic inclusion body myositis: A review of recent clinical advances and current approaches to diagnosis and treatment

Frank Mastaglia

Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology, 2015

View PDFchevron_right

Newest pathogenetic considerations in inclusion-body myositis: Possible role amyloid-β, cholesterol, relation to aging and to alzheimer’s disease

Valerie Askanas

Current Rheumatology Reports, 2002

View PDFchevron_right

Inclusion body myositis. Genetics, biomarkers and muscle biopsy

Ioannis Mavroudis

International Journal of Neuroscience, 2023

View PDFchevron_right

Targeting protein homeostasis in sporadic inclusion body myositis

Philip Gallagher

View PDFchevron_right

Sporadic inclusion body myositis: the genetic contributions to the pathogenesis

Qiang Gang

Orphanet J Rare Dis, 2014

View PDFchevron_right

Sporadic inclusion-body myositis: Recent advances and the state of the art in 2016

laure gallay

Revue Neurologique, 2016

View PDFchevron_right

Sporadic inclusion body myositis: morphology, regeneration, and cytoskeletal structure of muscle fibres

Kristian Borg

Journal of Neurology, Neurosurgery & Psychiatry, 2004

View PDFchevron_right

Inclusion body myositis: Clinical and pathological boundaries

Gil Wolfe

Annals of Neurology, 1996

View PDFchevron_right

Inclusion body myositis: therapeutic approaches

Chester Oddis

Degenerative Neurological and Neuromuscular Disease, 2012

View PDFchevron_right

Myostatin is increased and complexes with amyloid-β within sporadic inclusion-body myositis muscle fibers

Slawomir Wójcik

Acta Neuropathologica, 2005

View PDFchevron_right

Inclusion Body Myositis

Andrew Engel

The American Journal of Pathology, 2011

View PDFchevron_right

Emerging therapeutic options for sporadic inclusion body myositis

Linda Lowes

Therapeutics and Clinical Risk Management, 2015

View PDFchevron_right

Inclusion body myositis and myopathies

Andrew Engel

Annals of Neurology, 1995

View PDFchevron_right

Inclusion body myositis: from genetics to clinical trials

alaa khan

Journal of Neurology

View PDFchevron_right

Mitochondrial and inflammatory changes in sporadic Inclusion Body Myositis

Karolina Rygiel

Neuropathology and Applied Neurobiology, 2014

View PDFchevron_right

Unfolding Story of Inclusion-Body Myositis and Myopathies: Role of Misfolded Proteins, Amyloid-β, Cholesterol, and Aging

Valerie Askanas

Journal of Child Neurology, 2003

View PDFchevron_right

A retrospective cohort study identifying the principal pathological features useful in the diagnosis of inclusion body myositis

Stefen Brady

BMJ Open, 2014

View PDFchevron_right

Autoantibodies Produced at the Site of Tissue Damage Provide Evidence of Humoral Autoimmunity in Inclusion Body Myositis

Arundhati Ray

PLoS ONE, 2012

View PDFchevron_right

Inclusion body myositis and paraproteinemia: Incidence and immunopathologic correlations

Cándido Juárez

Annals of Neurology, 1997

View PDFchevron_right

Clinical Subgroups and Factors Associated With Progression in Patients With Inclusion Body Myositis

Lisa Christopher-stine

Neurology, 2023

View PDFchevron_right

Plasma cells in muscle in inclusion body myositis and polymyositis

Jack Pinkus

Neurology, 2005

View PDFchevron_right

Fast-twitch sarcomeric and glycolytic enzyme protein loss in inclusion body myositis

Jack Pinkus

Muscle & nerve, 2009

View PDFchevron_right